Results 131 to 140 of about 408,139 (189)

Persistent Pelvic Adhesions and Fibrotic Remodeling Following Ectopic Lesion Ablation in a Mouse Model of Endometriosis

The FASEB Journal, Volume 40, Issue 20, 31 October 2026.
DT‐mediated ablation eliminated detectable donor‐derived ectopic lesions. However, pelvic adhesions, collagen‐rich fibrosis, α‐SMA‐positive fibrotic remodeling, and functional behavioral alterations persisted. These findings indicate that lesion ablation alone is insufficient to resolve established adhesion‐associated fibrotic remodeling and identify ...
Sohyeon Yun, Kyeong A. So, Eunhee M. Jeong, Marissa G. Hoover, Abu Raihan, Lisa Brennaman, Jung‐Yoon Yoo, Andrew M. Kelleher, Tae Hoon Kim, Jung‐Ho Shin, Jae‐Wook Jeong   +10 more
wiley   +1 more source

Association of Neutrophil Percentage‐to‐Albumin Ratio (NPAR) With Pathological Features and Long‐Term Prognosis in Diabetic Kidney Disease: A Cohort Study

The FASEB Journal, Volume 40, Issue 19, 15 October 2026.
This graphical abstract summarizes the association between the neutrophil percentage‐to‐albumin ratio (NPAR), renal pathology, and prognosis in biopsy‐confirmed diabetic kidney disease. Higher NPAR was associated with increased renal MPO‐positive neutrophil infiltration, more severe histopathological injury, and poorer renal outcomes.
Yang Li, Hongyu Wang, Wendi He, Yi Fang, Shi Jin, Hong Liu, Jie Li, Nana Song, Xiaoqiang Ding, Yan Dai   +9 more
wiley   +1 more source

Effect of peritoneal dialysate on peritoneal fibrosis. [PDF]

BMC Nephrol
Dai Z, Zhou F, Li M, Lin H, Sheng Q, Luo Q.   +5 more
europepmc   +1 more source

Metabolic Remodeling in Peritoneal Dialysis-Associated Peritoneal Fibrosis: Mechanisms, Candidate Metabolic Signatures, and Therapeutic Perspectives. [PDF]

Metabolites
Zhu Z, Wang M, Zhang T, Li J, Yang B, Yang H.   +5 more
europepmc   +1 more source

The effects of colchicine on the progression and regression of encapsulation peritoneal sclerosis

, 2008
? Background: Encapsulating peritoneal sclerosis (EPS) is an infrequent but extremely serious complication of long-term peritoneal dialysis. Fibrosis of the submesothelial compact zone and neoangiogenesis underlie the pathophysiology of EPS.
Duman S., Ertilav M., Hur E., Şen S., Bicak S., Sipahi S., Bozkurt D., Taskin H.   +7 more
core  

Breaking barriers in peritoneal fibrosis: extracellular vesicles as promising diagnostic and therapeutic strategy. [PDF]

Ann Med
Zhong L, Zhang B, Li Y, Su B, Liao R.
europepmc   +1 more source

MEF2A nuclear translocation mediated by ROCK phosphorylation promotes EZH2 expression and peritoneal fibrosis. [PDF]

Ren Fail
Chen D, Sun Z, Xu Y, Wang Q.
europepmc   +1 more source

The clinical value of ⁶⁸Ga-FAPI to evaluate the peritoneal fibrosis and its inherent molecule relationship with POSTN and DPP7. [PDF]

J Transl Med
Xiao K, Zhang Y, Peng H, Niu M, Li G, Xu X, Zhang X, Yang Q, Zhao Y, He L.   +9 more
europepmc   +1 more source

Rosiglitazone, a peroxisome proliferator-activated receptor agonist, improves peritoneal alterations resulting from an encapsulated peritoneal sclerosis model.

, 2008
Inflammation, fibrosis, and angiogenesis underlie the pathophysiology of encapsulating peritoneal sclerosis (EPS). The irreversible sclerosis of visceral and parietal peritoneum that characterizes EPS can be seen in peritoneal dialysis (PD) patients ...
Duman S., Sezak M., Biçak S., Ok E., Bozkurt D., Sen S., Taskin H.   +6 more
core  

ADAM19 participated in peritoneal fibrosis by regulating M2 macrophage polarization in peritoneal dialysis patients. [PDF]

Sci Rep
Xu K, Yu J, He M, Jiang X, Yuan Y.
europepmc   +1 more source